Theravance Biopharma Inc
(NAS:TBPH)
$
9.105
-0.085 (-0.92%)
Market Cap: 447.73 Mil
Enterprise Value: 405.53 Mil
PE Ratio: 0
PB Ratio: 2.41
GF Score: 71/100 Theravance Biopharma Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 13, 2021 / 06:45PM GMT
Release Date Price:
$18.72
(-0.79%)
Tazeen Ahmad
BofA Securities, Research Division - VP
Good afternoon, everybody. Thanks so much for joining us at the Bank of America Healthcare Conference. It's my pleasure to have our next presenting company with me Theravance Biopharma. I have a long history with Theravance. You guys are one of the longest-running coverage companies that I've had going back over a decade, I think. So Rick, it's good to see you always. Rick Winningham, of course, CEO of Theravance Biopharma.
Rick E. Winningham
Theravance Biopharma, Inc. - Chairman & CEO
Great to see you, Tazeen, and thanks so much for the invitation.
Tazeen Ahmad
BofA Securities, Research Division - VP
Rick, you have a couple of colleagues with you on this call. I'll let you introduce them.
Rick E. Winningham
Theravance Biopharma, Inc. - Chairman & CEO
Sure. Joining me today are Andrew Hindman, our CFO; and Rick Graham, who's our Senior Vice President of Development and is responsible for the development
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot